SlideShare ist ein Scribd-Unternehmen logo
1 von 23
TB:	
  impa)o	
  
epidemiologico	
  sociale	
  



                         Dennis	
  FALZON	
  
          Stop	
  TB	
  Department,	
  OMS,	
  Svizzera	
  
              3°	
  CONVEGNO	
  NAZIONALE	
  
        TUBERCOLOSI:	
  UNA	
  MALATTIA	
  SOCIALE	
  
            ACQUARIO	
  CIVICO	
  DI	
  MILANO	
  
                   21-­‐22	
  SETTEMBRE	
  2012	
  
ORWELL	
  




  CHOPIN	
                     CAMUS	
                              BRONTE	
  
                                                                                   BOLIVAR	
  




                                                                   KAFKA	
  
CHEKOV	
           KEATS	
  
                                                                                   LAENNAC	
  
                                                   MOLIERE	
  



                                  MODIGLIANI	
  



    GORKIY	
     STEVENSON	
                        MORAVIA	
      RAMANUJAN	
       SILONE	
  
The	
  global	
  TB	
  situa?on	
  (1)	
  
                                                             Estimated number of                                  Estimated number of
                                                                  cases, 2010                                         deaths, 2010


  All	
  forms	
  of	
  TB	
                                            8.8	
  million	
                            	
  	
  	
  	
  1.1	
  million*	
  
                                                                    (8.5–9.2	
  million)	
                          (0.9–1.2	
  million)	
  

  HIV-­‐associated	
  TB	
                                              	
  	
  1.1	
  million	
                          350,000	
  
                                                                   	
  (1.0–1.2	
  million)	
                      (320,000–390,000)	
  

  Mul?drug-­‐                                                              ~	
  650,000	
  	
  
                                                         out	
  of	
  12	
  million	
  (11-­‐14	
  million)	
  
  resistant	
  TB	
                                                   prevalent	
  TB	
  cases	
  

                                                                                        *	
  Excluding	
  deaths	
  aXributed	
  to	
  HIV/TB	
  
Source:	
  WHO	
  Global	
  Tuberculosis	
  Control	
  Report	
  2011	
  (www.who.int/tb/publicaons/global_report/2011/gtbr11_full.pdf)	
  
            TB:	
  impa)o	
  epidemiologico	
  sociale	
  
   3 	
  
            3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
The	
  global	
  TB	
  situa?on	
  (2)	
  




         Countries	
  in	
  capitals	
  are	
  high	
  burden	
  for	
  TB	
  incidence	
  
         TB:	
  impa)o	
  epidemiologico	
  sociale	
  
4 	
  
         3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
The	
  global	
  TB	
  situa?on	
  (3)	
  
Es?mated	
  MDR-­‐TB	
  cases	
  among	
  no?fied	
  TB	
  pa?ents	
  in	
  2010	
  
 >60% of cases occur in Brazil, China, India, the Russian Federation and South Africa	
  




                                       No	
  data	
  
                                       0-­‐300	
  
                                       301-­‐3,000	
  
                                       3,001-­‐30,000	
  
                                       30,001-­‐60,000	
  
                                       >60,000	
  




The	
  boundaries	
  and	
  names	
  shown	
  and	
  the	
  designa?ons	
  used	
  on	
  this	
  map	
  do	
  not	
  imply	
  the	
  expression	
  of	
  any	
  opinion	
  whatsoever	
  on	
  the	
  part	
  of	
  the	
  World	
  Health	
  Organiza?on	
  concerning	
  
the	
  legal	
  status	
  of	
  any	
  country,	
  territory,	
  city	
  or	
  area	
  or	
  of	
  its	
  authori?es,	
  or	
  concerning	
  the	
  delimita?on	
  of	
  its	
  fron?ers	
  or	
  boundaries.	
  	
  DoXed	
  lines	
  on	
  maps	
  represent	
  approximate	
  border	
  
                                                                                                               lines	
  for	
  which	
  there	
  may	
  not	
  yet	
  be	
  full	
  agreement.	
  	
  
                                                                                                                                ©	
  WHO	
  2011.	
  All	
  rights	
  reserved	
  
Rudolph	
  Virchow:	
  	
  
                                              diagnosis	
  of	
  the	
  disease	
  of	
  which	
  TB	
  is	
  a	
  
                                              symptom	
  (1860)	
  

                                              "…it	
  shows	
  that	
  disturbances	
  exist	
  in	
  the	
  
                                              development	
  of	
  our	
  popula?ons,	
  disturbances	
  
                                              which	
  arise	
  from	
  poli4cal	
  and	
  social	
  ins4tu4ons,	
  
                                              and	
  are	
  therefore	
  preventable".	
  
                                              Robert	
  Koch:	
  	
  
                                              Offered	
  an	
  early	
  intervenon	
  strategy	
  to	
  cure	
  
                                              that	
  disease	
  (Nobel	
  laureate	
  1905)	
  
                                              "One	
  of	
  the	
  most	
  powerful	
  weapons,	
  if	
  not	
  the	
  most	
  
                                              powerful,	
  which	
  we	
  can	
  bring	
  into	
  use	
  against	
  TB	
  are	
  social	
  
                                              welfare	
  centres:	
  	
  	
  
                                                       –  …the	
  sick	
  person	
  is	
  visited	
  in	
  his	
  home,	
  and	
  is	
  given	
  instruc?on	
  and	
  advice	
  
                                                          concerning	
  cleanliness.	
  	
  
                                                       –  …If	
  living	
  condi?ons	
  are	
  bad,	
  then	
  money	
  is	
  granted…	
  	
  
                                                       –  …poor	
  families	
  are	
  supported	
  by	
  gran?ng	
  them	
  appropriate	
  food,	
  fuel,	
  etc".	
  	
  
                                                       –  …private	
  ac?on	
  is	
  virtually	
  powerless	
  against	
  this	
  nuisance,	
  while	
  the	
  State	
  
                                                          can	
  easily	
  remedy	
  the	
  situa?on	
  with	
  suitable	
  laws"	
  	
  


         TB:	
  impa)o	
  epidemiologico	
  sociale	
  
6 	
  
         3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
Rise	
  and	
  fall	
  in	
  18th	
  and	
  19th	
  century	
  Europe:	
  
                        economic	
  and	
  social	
  factors	
  	
  




         TB:	
  impa)o	
  epidemiologico	
  sociale	
  
7 	
  
         3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
20th	
  century:	
  
                      2000
                                       Declining	
  TB	
  deaths	
  in	
  England	
  and	
  Wales	
  
                                             World War 1

                      1500



                                                                                      Test tubes with streptomycin 1946
                      1000
                                                                     World War 2


                        500




                             0
                            1900                         1920        1940          1960               1980

         TB:	
  impa)o	
  epidemiologico	
  sociale	
  
8 	
  
         3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
TB	
  case	
  noficaon	
  in	
  Eastern	
  Europe	
  
                                 	
  Increase	
  in	
  cases	
  aeer	
  independence	
  
      TB cases / 100,000
240


                                                                                                                Kazakhstan
200                                                                                                             Rep. of Moldova

                                                                                                                Georgia *

160                                                                                                             Kyrgyzstan

                                                                                                                Tajikistan

                                                                                                                Russian Federation
120
                                                                                                                Uzbekistan

                                                                                                                Azerbaijan

80                                                                                                              Ukraine

                                                                                                                Armenia

                                                                                                                Turkmenistan
40
                                                                                                                Belarus



 0
          1995        1996        1997         1998        1999       2000   2001   2002   2003   2004   2005


          TB:	
  impa)o	
  epidemiologico	
  sociale	
  
 9 	
  
          3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
TB	
  case	
  noficaon	
  in	
  the	
  European	
  Union	
  
          	
  Reversal	
  in	
  TB	
  rates	
  in	
  early	
  1990s	
  in	
  several	
  countries	
  
                  TB cases / 100 000 pop	
  
          100

            90

            80

            70

            60
                                                                                   Baltic States

            50
                                                                                   Other EU countries*

            40

            30

            20

            10




          TB:	
  impa)o	
  epidemiologico	
  sociale	
  
10 	
  
          3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
TB	
  and	
  migra?on:	
  Italy	
  




                 Odone	
  A	
  et	
  al.	
  BMC	
  Public	
  Health	
  2011,	
  11:376	
  
Dose–response	
  rela?onship	
  in	
  the	
  reviewed	
  cohort	
  studies	
  on	
  the	
  associa?on	
  between	
  BMI	
  and	
  TB	
  
     incidence.	
  The	
  lines	
  refer	
  to	
  values	
  from	
  different	
  studies	
  (see	
  Lönnroth	
  K	
  et	
  al.	
  A	
  consistent	
  log-­‐
     linear	
  rela?onship	
  between	
  tuberculosis	
  incidence	
  and	
  body	
  mass	
  index.	
  Inter	
  J	
  Epidemiol.	
  2009.	
  
     9;39(1):149–55.)	
  
          TB:	
  impa)o	
  epidemiologico	
  sociale	
  
12 	
  
          3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
Overlapping	
  risks	
  for	
  TB	
  :	
  United	
  Kingdom	
  




                                     Story	
  A	
  et	
  al.	
  Thorax	
  2007;62:667–671	
  
"The possibility of eradicating TB in a country is essentially a
function of its economic level" (G. Canetti, 1962)

  TB incidence rates & socio-economic level, New York, 1973
  (SE level estimated on the basis of education, occupation and income)

                                                                       -more crowding?
                                                                       -higher prevalence of HIV, smoking,
                                                                       malnutrition, alcoholism, social
                                                                       marginalization etc?
                                                                                -poor access to health services,
                                                                                diagnostic delays, prolonged
                                                                                infectiousness in poor
                                                                                communities?




                                                                                      Hinman AR et al, Am J Epidem 103:490, 1976
           TB:	
  impa)o	
  epidemiologico	
  sociale	
  
 14 	
  
           3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
Eur Respir J. 2008. 32 sociale	
  
     TB:	
  impa)o	
  epidemiologico	
   (5):1415-1416
15 	
  
          3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
A. Human development


An ecologic analysis:
                                                                                                         15




                                                                           Change TB incidence (%/yr)
                                                                                                                                                                    2
                                                                                                                                                                   R = 0.20
                                                                                                         10




associations at global
                                                                                                          5

                                                                                                          0




level
                                                                                                         -5

                                                                                                        -10

                                                                                                        -15
(Bull WHO 2009;87:683-691)                                                                                     3       4           5     6         7      8        9            10
                                                                                                                           Human Development Index (arcsin*1000)


                                                                                                               B. Child mortality
                                                                                                        12




                                                                       Change TB incidence (%/yr)
 Data for 134 countries
                                                                                                         8

                                                                                                         4


 from 1997-2006                                                                                          0

                                                                                                         -4

                                                                                                         -8                                                         2
                                                                                                                                                                  R = 0.25

 TB incidence depends                                                                                   -12
                                                                                                              0.4            0.9             1.4         1.9              2.4


 also on development level
                                                                                                                    Child deaths under 5 years per 1000 births (log 10)

                                                                                                                C. Sanitation
                                                                                                         15




                                                                           Change TB incidence (%/yr)
                                                                                                                                                                    2
                                                                                                                                                                  R = 0.26
                                                                                                         10

                                                                                                          5


 HDI is calculated based on life
                                                                                                          0

                                                                                                         -5

 expectancy, literacy rate, and                                                                         -10

 GDP/capita                                                                                             -15
                                                                                                              0.2     0.4          0.6   0.8       1.0   1.2      1.4           1.6
                                                                                                                      Population with improved sanitation (arcsin %)




           TB:	
  impa)o	
  epidemiologico	
  sociale	
  
 16 	
  
           3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
The links between M/XDR-TB & poverty
A	
  vicious	
  cycle	
  :	
  
1.  Poor	
  pa?ents	
  more	
  likely	
  to	
  interrupt	
  TB	
  treatment	
  :	
  lack	
  of	
  
            health	
  coverage,	
  cheaper	
  and	
  poor	
  quality	
  drugs,	
  need	
  for	
  
            gainful	
  employment	
  

2.  Once	
  MDR-­‐TB	
  develops,	
  it	
  is	
  more	
  likely	
  to	
  go	
  untreated	
  owing	
  
            to	
  the	
  high	
  cost	
  of	
  care	
  

3.  Overcrowding	
  in	
  residence	
  and	
  in	
  hospitals	
  may	
  promote	
  
            transmission	
  of	
  emergent	
  drug-­‐resistant	
  to	
  others	
  

4.  HIV	
  may	
  also	
  be	
  poverty	
  related	
  and	
  when	
  combined	
  with	
  DR-­‐TB	
  
            makes	
  for	
  a	
  fatal	
  combina?on	
  
           TB:	
  impa)o	
  epidemiologico	
  sociale	
  
 17 	
  
           3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
Can extreme poverty favour M/XDR-TB?

1.  If one agrees that poverty and
    impoverishment favour TB, then
    MDR-TB is exacerbated even
    further

2.  A study at Wardha District, India,
    showed that compliance to
    treatment depends upon family
    income and housing (Barnhoorn &
           Adriaanse, 1992)

3.  "Throughout the world, those
    least likely to comply are those
    least able to comply" (Farmer, 1999)
4.  Mono-therapy may be the result
    of cash exhaustion by patients
    and scarce financing by countries
           TB:	
  impa)o	
  epidemiologico	
  sociale	
  
 18 	
  
           3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
Poverty-­‐disease	
  trap	
  (1)	
  




                                                             Health in all policies,
                                                             UHC, public health
            Wealth and wealth
                                        as	
  applied	
  to	
  TB	
  




                                                                                                                         TB diagnosis and
                                              •    Undernutri?on	
  
            distribution




                                                                                                                         treatment
                                              •    Poor	
  housing	
  
                                              •    Risk	
  factors	
  for	
  infec?ous	
  diseases	
  and	
  NCDs	
  
                                              •    Poor	
  health	
  care	
  access	
  


                                                                                       Social and financial
Poverty	
                                                                                                                TB	
  
                                                                                       support

                                                   •  Worse	
  health	
  and	
  s?gma	
  –	
  loss	
  of	
  income	
  
                                                   •  Catastrophic	
  health	
  expenditure:	
  
                                                   •  10-­‐50%	
  of	
  annual	
  income	
  lost!	
  

           TB:	
  impa)o	
  epidemiologico	
  sociale	
  
 19 	
  
           3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
Poverty-­‐disease	
  trap	
  (2)	
  
              Doing	
  something	
  about	
  it:	
  condi?onal	
  cash	
  transfers	
  

                                                                      Reaching	
  Mexico’s	
  poorest	
  
                                                                      The	
  poorest	
  people	
  oeen	
  use	
  health	
  
                                                                                 services	
  less	
  than	
  their	
  more	
  
                                                                        affluent	
  counterparts,	
  even	
  when	
  
                                                                                          those	
  services	
  are	
  free	
  
                                                                              of	
  charge	
  and	
  widely	
  available.	
  
                                                                                                                          	
  
                                                                               The	
  Oportunidades	
  project	
  in	
  
                                                                         Mexico	
  is	
  redressing	
  the	
  balance.	
  


                                                                                    Bulletin of the World Health Organization
                                                                                                          August 2006, 84 (8)

          TB:	
  impa)o	
  epidemiologico	
  sociale	
  
20 	
  
          3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
The role of social protection in TB control
1.  TB care & control:
    •  Improve acceptability, relevance and attractiveness of services
    •  Enable access to improve early and free diagnosis
    •  Support patients, families and communities to improve outcomes

2.  Health systems and policies:
    •  Universal health coverage, including social & financial protection
    •  Integrated approach to address patients' health and social needs

3.  Sustainable development:
    •  Contribute to poverty reduction for TB patients, families,
       communities, and vulnerable groups

4.  Research:
    •  Build evidence base through operational research on delivery
       models, feasibility, local adaptation, and cost-effectiveness


          TB:	
  impa)o	
  epidemiologico	
  sociale	
  
21 	
  
          3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
Enabler	
  and	
  social	
  protec?on	
  package	
  
1.  Free	
  clinical	
  package	
  
            –  TB	
  diagnosis	
  and	
  treatment	
  
            –  Co-­‐morbidi?es	
  (HIV,	
  substance	
  abuse,	
  
               undernutri?on,	
  diabetes,	
  etc)	
  

2.  Support	
  package	
  
            –    Health	
  informa?on	
  and	
  psychosocial	
  support	
  
            –    Cash	
  transfer	
  
            –    Travel	
  vouchers	
  
            –    Food	
  assistance	
  
            –    Housing	
  assistance	
  
            –    Voca?onal	
  training,	
  income	
  genera?on,	
  
                 microcredit	
  

3.  Regulaon	
  and	
  structural	
  intervenons	
  
            –  Workers'	
  protec?on	
  	
  
            –  Sickness	
  insurance	
  &	
  welfare	
  benefits	
  
            TB:	
  impa)o	
  epidemiologico	
  sociale	
  
  22 	
  
            3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  
Acknowledgements:	
  
             	
  Mario	
  Raviglione	
  
             	
  Knut	
  Lönnroth	
  
             	
  Ernesto	
  Jaramillo	
  
             	
  	
  
             	
  others	
  at	
  the	
  Stop	
  TB	
  Dept	
  


          TB:	
  impa)o	
  epidemiologico	
  sociale	
  
23 	
  
          3°convegno	
  nazionale	
  TB	
  –	
  Milano	
  09/12	
  

Weitere ähnliche Inhalte

Ähnlich wie PPT Falzon "Epidemiological social impact"

Life and death in a pandemic
Life and death in a pandemicLife and death in a pandemic
Life and death in a pandemicNicolae Sfetcu
 
Tuberculosis: Why are we still fighting tb final
Tuberculosis: Why are we still fighting tb finalTuberculosis: Why are we still fighting tb final
Tuberculosis: Why are we still fighting tb finalSHERIFFMUIDEEN1
 
Training on tuberculosis for counselors 2012
Training on tuberculosis for counselors 2012Training on tuberculosis for counselors 2012
Training on tuberculosis for counselors 2012Madhu Oswal
 
Bio303 Lecture 2 Two Old Enemies, TB and Leprosy
Bio303 Lecture 2 Two Old Enemies, TB and LeprosyBio303 Lecture 2 Two Old Enemies, TB and Leprosy
Bio303 Lecture 2 Two Old Enemies, TB and LeprosyMark Pallen
 
Definition of tuberculosis as scientific and practical problem
Definition of tuberculosis as scientific and practical problemDefinition of tuberculosis as scientific and practical problem
Definition of tuberculosis as scientific and practical problemOleksandr Ivashchenko
 
Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.  Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis. AB Rajar
 
Child and Family Impacts of the Coronavirus Syndemic: Developmental, Family, ...
Child and Family Impacts of the Coronavirus Syndemic: Developmental, Family, ...Child and Family Impacts of the Coronavirus Syndemic: Developmental, Family, ...
Child and Family Impacts of the Coronavirus Syndemic: Developmental, Family, ...Université de Montréal
 
Tuberculosis: The Invisible Threat
Tuberculosis: The Invisible ThreatTuberculosis: The Invisible Threat
Tuberculosis: The Invisible Threatjayembee
 
Health Transition.pptx
Health Transition.pptxHealth Transition.pptx
Health Transition.pptxRiaz Mangi
 
t-140513165753-phpapp02.pptx
t-140513165753-phpapp02.pptxt-140513165753-phpapp02.pptx
t-140513165753-phpapp02.pptxAshraf Shaik
 
tuberculosis ppt by laxmi prasanna vemireddy
tuberculosis ppt by laxmi prasanna vemireddytuberculosis ppt by laxmi prasanna vemireddy
tuberculosis ppt by laxmi prasanna vemireddyLaxmi Prasanna Vemireddy
 

Ähnlich wie PPT Falzon "Epidemiological social impact" (17)

Life and death in a pandemic
Life and death in a pandemicLife and death in a pandemic
Life and death in a pandemic
 
Tuberculosis: Why are we still fighting tb final
Tuberculosis: Why are we still fighting tb finalTuberculosis: Why are we still fighting tb final
Tuberculosis: Why are we still fighting tb final
 
Tb rev3
Tb rev3Tb rev3
Tb rev3
 
Training on tuberculosis for counselors 2012
Training on tuberculosis for counselors 2012Training on tuberculosis for counselors 2012
Training on tuberculosis for counselors 2012
 
Eradication of smallpox in 20th Century: an unrepeatable success?, David Heym...
Eradication of smallpox in 20th Century: an unrepeatable success?, David Heym...Eradication of smallpox in 20th Century: an unrepeatable success?, David Heym...
Eradication of smallpox in 20th Century: an unrepeatable success?, David Heym...
 
Bio303 Lecture 2 Two Old Enemies, TB and Leprosy
Bio303 Lecture 2 Two Old Enemies, TB and LeprosyBio303 Lecture 2 Two Old Enemies, TB and Leprosy
Bio303 Lecture 2 Two Old Enemies, TB and Leprosy
 
Definition of tuberculosis as scientific and practical problem
Definition of tuberculosis as scientific and practical problemDefinition of tuberculosis as scientific and practical problem
Definition of tuberculosis as scientific and practical problem
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis
Tuberculosis Tuberculosis
Tuberculosis
 
Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.  Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.
 
Child and Family Impacts of the Coronavirus Syndemic: Developmental, Family, ...
Child and Family Impacts of the Coronavirus Syndemic: Developmental, Family, ...Child and Family Impacts of the Coronavirus Syndemic: Developmental, Family, ...
Child and Family Impacts of the Coronavirus Syndemic: Developmental, Family, ...
 
Tuberculosis: The Invisible Threat
Tuberculosis: The Invisible ThreatTuberculosis: The Invisible Threat
Tuberculosis: The Invisible Threat
 
eHealth Resources for Controling AIDS in Brazil
eHealth Resources for Controling AIDS in BrazileHealth Resources for Controling AIDS in Brazil
eHealth Resources for Controling AIDS in Brazil
 
1. Intro
1. Intro1. Intro
1. Intro
 
Health Transition.pptx
Health Transition.pptxHealth Transition.pptx
Health Transition.pptx
 
t-140513165753-phpapp02.pptx
t-140513165753-phpapp02.pptxt-140513165753-phpapp02.pptx
t-140513165753-phpapp02.pptx
 
tuberculosis ppt by laxmi prasanna vemireddy
tuberculosis ppt by laxmi prasanna vemireddytuberculosis ppt by laxmi prasanna vemireddy
tuberculosis ppt by laxmi prasanna vemireddy
 

Mehr von StopTb Italia

PPT Messa "Un tributo pagato dall'arte"
PPT Messa "Un tributo pagato dall'arte"PPT Messa "Un tributo pagato dall'arte"
PPT Messa "Un tributo pagato dall'arte"StopTb Italia
 
PPT Rizzardini "HAART, sostenibilità di un miracolo"
PPT Rizzardini "HAART, sostenibilità di un miracolo"PPT Rizzardini "HAART, sostenibilità di un miracolo"
PPT Rizzardini "HAART, sostenibilità di un miracolo"StopTb Italia
 
PPT Ranieri "HIV e TB in carcere"
PPT Ranieri "HIV e TB in carcere"PPT Ranieri "HIV e TB in carcere"
PPT Ranieri "HIV e TB in carcere"StopTb Italia
 
PPT Fiorentini "TB tra ospedale e territorio"
PPT Fiorentini "TB tra ospedale e territorio"PPT Fiorentini "TB tra ospedale e territorio"
PPT Fiorentini "TB tra ospedale e territorio"StopTb Italia
 
PPT Rusconi "Le multiresistenze dell'HIV/AIDS"
PPT Rusconi "Le multiresistenze dell'HIV/AIDS"PPT Rusconi "Le multiresistenze dell'HIV/AIDS"
PPT Rusconi "Le multiresistenze dell'HIV/AIDS"StopTb Italia
 
PPT Besozzi "Le multiresistenze della TB"
PPT Besozzi "Le multiresistenze della TB"PPT Besozzi "Le multiresistenze della TB"
PPT Besozzi "Le multiresistenze della TB"StopTb Italia
 
PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"
PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"
PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"StopTb Italia
 
PPT Concia "Localizzazioni extrapolmonari nella coinfezione"
PPT Concia "Localizzazioni extrapolmonari nella coinfezione"PPT Concia "Localizzazioni extrapolmonari nella coinfezione"
PPT Concia "Localizzazioni extrapolmonari nella coinfezione"StopTb Italia
 
PPT Lapadula "Clinica e terapia in TB/HIV"
PPT Lapadula "Clinica e terapia in TB/HIV"PPT Lapadula "Clinica e terapia in TB/HIV"
PPT Lapadula "Clinica e terapia in TB/HIV"StopTb Italia
 
PPT Bonora "Clinica e terapia dell'HIV"
PPT Bonora "Clinica e terapia dell'HIV"PPT Bonora "Clinica e terapia dell'HIV"
PPT Bonora "Clinica e terapia dell'HIV"StopTb Italia
 
PPT Cirillo "La diagnosi di tubercolosi"
PPT Cirillo "La diagnosi di tubercolosi"PPT Cirillo "La diagnosi di tubercolosi"
PPT Cirillo "La diagnosi di tubercolosi"StopTb Italia
 
PPT Gori "Immunologia TB/HIV"
PPT Gori "Immunologia TB/HIV"PPT Gori "Immunologia TB/HIV"
PPT Gori "Immunologia TB/HIV"StopTb Italia
 
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"StopTb Italia
 
PPT Bocchino "Diagnosi dell'infezione tubercolare"
PPT Bocchino "Diagnosi dell'infezione tubercolare"PPT Bocchino "Diagnosi dell'infezione tubercolare"
PPT Bocchino "Diagnosi dell'infezione tubercolare"StopTb Italia
 
PPT Angarano "Storia naturale dell'HIV"
PPT Angarano "Storia naturale dell'HIV"PPT Angarano "Storia naturale dell'HIV"
PPT Angarano "Storia naturale dell'HIV"StopTb Italia
 
PPT Casali "Storia naturale della TB"
PPT Casali "Storia naturale della TB"PPT Casali "Storia naturale della TB"
PPT Casali "Storia naturale della TB"StopTb Italia
 
PPT Girardi "Epidemiologia della confezione TB-HIV"
PPT Girardi "Epidemiologia della confezione TB-HIV"PPT Girardi "Epidemiologia della confezione TB-HIV"
PPT Girardi "Epidemiologia della confezione TB-HIV"StopTb Italia
 
PPT Pezzotti "Epidemiologia dell'HIV"
PPT Pezzotti "Epidemiologia dell'HIV"PPT Pezzotti "Epidemiologia dell'HIV"
PPT Pezzotti "Epidemiologia dell'HIV"StopTb Italia
 
PPT Matteelli "Epidemiologia della TB"
PPT Matteelli "Epidemiologia della TB"PPT Matteelli "Epidemiologia della TB"
PPT Matteelli "Epidemiologia della TB"StopTb Italia
 

Mehr von StopTb Italia (20)

PPT Messa "Un tributo pagato dall'arte"
PPT Messa "Un tributo pagato dall'arte"PPT Messa "Un tributo pagato dall'arte"
PPT Messa "Un tributo pagato dall'arte"
 
PPT Rizzardini "HAART, sostenibilità di un miracolo"
PPT Rizzardini "HAART, sostenibilità di un miracolo"PPT Rizzardini "HAART, sostenibilità di un miracolo"
PPT Rizzardini "HAART, sostenibilità di un miracolo"
 
PPT Ranieri "HIV e TB in carcere"
PPT Ranieri "HIV e TB in carcere"PPT Ranieri "HIV e TB in carcere"
PPT Ranieri "HIV e TB in carcere"
 
PPT Fiorentini "TB tra ospedale e territorio"
PPT Fiorentini "TB tra ospedale e territorio"PPT Fiorentini "TB tra ospedale e territorio"
PPT Fiorentini "TB tra ospedale e territorio"
 
PPT Rusconi "Le multiresistenze dell'HIV/AIDS"
PPT Rusconi "Le multiresistenze dell'HIV/AIDS"PPT Rusconi "Le multiresistenze dell'HIV/AIDS"
PPT Rusconi "Le multiresistenze dell'HIV/AIDS"
 
PPT Besozzi "Le multiresistenze della TB"
PPT Besozzi "Le multiresistenze della TB"PPT Besozzi "Le multiresistenze della TB"
PPT Besozzi "Le multiresistenze della TB"
 
PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"
PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"
PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"
 
PPT Concia "Localizzazioni extrapolmonari nella coinfezione"
PPT Concia "Localizzazioni extrapolmonari nella coinfezione"PPT Concia "Localizzazioni extrapolmonari nella coinfezione"
PPT Concia "Localizzazioni extrapolmonari nella coinfezione"
 
PPT Lapadula "Clinica e terapia in TB/HIV"
PPT Lapadula "Clinica e terapia in TB/HIV"PPT Lapadula "Clinica e terapia in TB/HIV"
PPT Lapadula "Clinica e terapia in TB/HIV"
 
PPT Bonora "Clinica e terapia dell'HIV"
PPT Bonora "Clinica e terapia dell'HIV"PPT Bonora "Clinica e terapia dell'HIV"
PPT Bonora "Clinica e terapia dell'HIV"
 
PPT Casali
PPT CasaliPPT Casali
PPT Casali
 
PPT Cirillo "La diagnosi di tubercolosi"
PPT Cirillo "La diagnosi di tubercolosi"PPT Cirillo "La diagnosi di tubercolosi"
PPT Cirillo "La diagnosi di tubercolosi"
 
PPT Gori "Immunologia TB/HIV"
PPT Gori "Immunologia TB/HIV"PPT Gori "Immunologia TB/HIV"
PPT Gori "Immunologia TB/HIV"
 
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
 
PPT Bocchino "Diagnosi dell'infezione tubercolare"
PPT Bocchino "Diagnosi dell'infezione tubercolare"PPT Bocchino "Diagnosi dell'infezione tubercolare"
PPT Bocchino "Diagnosi dell'infezione tubercolare"
 
PPT Angarano "Storia naturale dell'HIV"
PPT Angarano "Storia naturale dell'HIV"PPT Angarano "Storia naturale dell'HIV"
PPT Angarano "Storia naturale dell'HIV"
 
PPT Casali "Storia naturale della TB"
PPT Casali "Storia naturale della TB"PPT Casali "Storia naturale della TB"
PPT Casali "Storia naturale della TB"
 
PPT Girardi "Epidemiologia della confezione TB-HIV"
PPT Girardi "Epidemiologia della confezione TB-HIV"PPT Girardi "Epidemiologia della confezione TB-HIV"
PPT Girardi "Epidemiologia della confezione TB-HIV"
 
PPT Pezzotti "Epidemiologia dell'HIV"
PPT Pezzotti "Epidemiologia dell'HIV"PPT Pezzotti "Epidemiologia dell'HIV"
PPT Pezzotti "Epidemiologia dell'HIV"
 
PPT Matteelli "Epidemiologia della TB"
PPT Matteelli "Epidemiologia della TB"PPT Matteelli "Epidemiologia della TB"
PPT Matteelli "Epidemiologia della TB"
 

PPT Falzon "Epidemiological social impact"

  • 1. TB:  impa)o   epidemiologico  sociale   Dennis  FALZON   Stop  TB  Department,  OMS,  Svizzera   3°  CONVEGNO  NAZIONALE   TUBERCOLOSI:  UNA  MALATTIA  SOCIALE   ACQUARIO  CIVICO  DI  MILANO   21-­‐22  SETTEMBRE  2012  
  • 2. ORWELL   CHOPIN   CAMUS   BRONTE   BOLIVAR   KAFKA   CHEKOV   KEATS   LAENNAC   MOLIERE   MODIGLIANI   GORKIY   STEVENSON   MORAVIA   RAMANUJAN   SILONE  
  • 3. The  global  TB  situa?on  (1)   Estimated number of Estimated number of cases, 2010 deaths, 2010 All  forms  of  TB   8.8  million          1.1  million*   (8.5–9.2  million)   (0.9–1.2  million)   HIV-­‐associated  TB      1.1  million   350,000    (1.0–1.2  million)   (320,000–390,000)   Mul?drug-­‐ ~  650,000     out  of  12  million  (11-­‐14  million)   resistant  TB   prevalent  TB  cases   *  Excluding  deaths  aXributed  to  HIV/TB   Source:  WHO  Global  Tuberculosis  Control  Report  2011  (www.who.int/tb/publicaons/global_report/2011/gtbr11_full.pdf)   TB:  impa)o  epidemiologico  sociale   3   3°convegno  nazionale  TB  –  Milano  09/12  
  • 4. The  global  TB  situa?on  (2)   Countries  in  capitals  are  high  burden  for  TB  incidence   TB:  impa)o  epidemiologico  sociale   4   3°convegno  nazionale  TB  –  Milano  09/12  
  • 5. The  global  TB  situa?on  (3)   Es?mated  MDR-­‐TB  cases  among  no?fied  TB  pa?ents  in  2010   >60% of cases occur in Brazil, China, India, the Russian Federation and South Africa   No  data   0-­‐300   301-­‐3,000   3,001-­‐30,000   30,001-­‐60,000   >60,000   The  boundaries  and  names  shown  and  the  designa?ons  used  on  this  map  do  not  imply  the  expression  of  any  opinion  whatsoever  on  the  part  of  the  World  Health  Organiza?on  concerning   the  legal  status  of  any  country,  territory,  city  or  area  or  of  its  authori?es,  or  concerning  the  delimita?on  of  its  fron?ers  or  boundaries.    DoXed  lines  on  maps  represent  approximate  border   lines  for  which  there  may  not  yet  be  full  agreement.     ©  WHO  2011.  All  rights  reserved  
  • 6. Rudolph  Virchow:     diagnosis  of  the  disease  of  which  TB  is  a   symptom  (1860)   "…it  shows  that  disturbances  exist  in  the   development  of  our  popula?ons,  disturbances   which  arise  from  poli4cal  and  social  ins4tu4ons,   and  are  therefore  preventable".   Robert  Koch:     Offered  an  early  intervenon  strategy  to  cure   that  disease  (Nobel  laureate  1905)   "One  of  the  most  powerful  weapons,  if  not  the  most   powerful,  which  we  can  bring  into  use  against  TB  are  social   welfare  centres:       –  …the  sick  person  is  visited  in  his  home,  and  is  given  instruc?on  and  advice   concerning  cleanliness.     –  …If  living  condi?ons  are  bad,  then  money  is  granted…     –  …poor  families  are  supported  by  gran?ng  them  appropriate  food,  fuel,  etc".     –  …private  ac?on  is  virtually  powerless  against  this  nuisance,  while  the  State   can  easily  remedy  the  situa?on  with  suitable  laws"     TB:  impa)o  epidemiologico  sociale   6   3°convegno  nazionale  TB  –  Milano  09/12  
  • 7. Rise  and  fall  in  18th  and  19th  century  Europe:   economic  and  social  factors     TB:  impa)o  epidemiologico  sociale   7   3°convegno  nazionale  TB  –  Milano  09/12  
  • 8. 20th  century:   2000 Declining  TB  deaths  in  England  and  Wales   World War 1 1500 Test tubes with streptomycin 1946 1000 World War 2 500 0 1900 1920 1940 1960 1980 TB:  impa)o  epidemiologico  sociale   8   3°convegno  nazionale  TB  –  Milano  09/12  
  • 9. TB  case  noficaon  in  Eastern  Europe    Increase  in  cases  aeer  independence   TB cases / 100,000 240 Kazakhstan 200 Rep. of Moldova Georgia * 160 Kyrgyzstan Tajikistan Russian Federation 120 Uzbekistan Azerbaijan 80 Ukraine Armenia Turkmenistan 40 Belarus 0 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 TB:  impa)o  epidemiologico  sociale   9   3°convegno  nazionale  TB  –  Milano  09/12  
  • 10. TB  case  noficaon  in  the  European  Union    Reversal  in  TB  rates  in  early  1990s  in  several  countries   TB cases / 100 000 pop   100 90 80 70 60 Baltic States 50 Other EU countries* 40 30 20 10 TB:  impa)o  epidemiologico  sociale   10   3°convegno  nazionale  TB  –  Milano  09/12  
  • 11. TB  and  migra?on:  Italy   Odone  A  et  al.  BMC  Public  Health  2011,  11:376  
  • 12. Dose–response  rela?onship  in  the  reviewed  cohort  studies  on  the  associa?on  between  BMI  and  TB   incidence.  The  lines  refer  to  values  from  different  studies  (see  Lönnroth  K  et  al.  A  consistent  log-­‐ linear  rela?onship  between  tuberculosis  incidence  and  body  mass  index.  Inter  J  Epidemiol.  2009.   9;39(1):149–55.)   TB:  impa)o  epidemiologico  sociale   12   3°convegno  nazionale  TB  –  Milano  09/12  
  • 13. Overlapping  risks  for  TB  :  United  Kingdom   Story  A  et  al.  Thorax  2007;62:667–671  
  • 14. "The possibility of eradicating TB in a country is essentially a function of its economic level" (G. Canetti, 1962) TB incidence rates & socio-economic level, New York, 1973 (SE level estimated on the basis of education, occupation and income) -more crowding? -higher prevalence of HIV, smoking, malnutrition, alcoholism, social marginalization etc? -poor access to health services, diagnostic delays, prolonged infectiousness in poor communities? Hinman AR et al, Am J Epidem 103:490, 1976 TB:  impa)o  epidemiologico  sociale   14   3°convegno  nazionale  TB  –  Milano  09/12  
  • 15. Eur Respir J. 2008. 32 sociale   TB:  impa)o  epidemiologico   (5):1415-1416 15   3°convegno  nazionale  TB  –  Milano  09/12  
  • 16. A. Human development An ecologic analysis: 15 Change TB incidence (%/yr) 2 R = 0.20 10 associations at global 5 0 level -5 -10 -15 (Bull WHO 2009;87:683-691) 3 4 5 6 7 8 9 10 Human Development Index (arcsin*1000) B. Child mortality 12 Change TB incidence (%/yr) Data for 134 countries 8 4 from 1997-2006 0 -4 -8 2 R = 0.25 TB incidence depends -12 0.4 0.9 1.4 1.9 2.4 also on development level Child deaths under 5 years per 1000 births (log 10) C. Sanitation 15 Change TB incidence (%/yr) 2 R = 0.26 10 5 HDI is calculated based on life 0 -5 expectancy, literacy rate, and -10 GDP/capita -15 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 Population with improved sanitation (arcsin %) TB:  impa)o  epidemiologico  sociale   16   3°convegno  nazionale  TB  –  Milano  09/12  
  • 17. The links between M/XDR-TB & poverty A  vicious  cycle  :   1.  Poor  pa?ents  more  likely  to  interrupt  TB  treatment  :  lack  of   health  coverage,  cheaper  and  poor  quality  drugs,  need  for   gainful  employment   2.  Once  MDR-­‐TB  develops,  it  is  more  likely  to  go  untreated  owing   to  the  high  cost  of  care   3.  Overcrowding  in  residence  and  in  hospitals  may  promote   transmission  of  emergent  drug-­‐resistant  to  others   4.  HIV  may  also  be  poverty  related  and  when  combined  with  DR-­‐TB   makes  for  a  fatal  combina?on   TB:  impa)o  epidemiologico  sociale   17   3°convegno  nazionale  TB  –  Milano  09/12  
  • 18. Can extreme poverty favour M/XDR-TB? 1.  If one agrees that poverty and impoverishment favour TB, then MDR-TB is exacerbated even further 2.  A study at Wardha District, India, showed that compliance to treatment depends upon family income and housing (Barnhoorn & Adriaanse, 1992) 3.  "Throughout the world, those least likely to comply are those least able to comply" (Farmer, 1999) 4.  Mono-therapy may be the result of cash exhaustion by patients and scarce financing by countries TB:  impa)o  epidemiologico  sociale   18   3°convegno  nazionale  TB  –  Milano  09/12  
  • 19. Poverty-­‐disease  trap  (1)   Health in all policies, UHC, public health Wealth and wealth as  applied  to  TB   TB diagnosis and •  Undernutri?on   distribution treatment •  Poor  housing   •  Risk  factors  for  infec?ous  diseases  and  NCDs   •  Poor  health  care  access   Social and financial Poverty   TB   support •  Worse  health  and  s?gma  –  loss  of  income   •  Catastrophic  health  expenditure:   •  10-­‐50%  of  annual  income  lost!   TB:  impa)o  epidemiologico  sociale   19   3°convegno  nazionale  TB  –  Milano  09/12  
  • 20. Poverty-­‐disease  trap  (2)   Doing  something  about  it:  condi?onal  cash  transfers   Reaching  Mexico’s  poorest   The  poorest  people  oeen  use  health   services  less  than  their  more   affluent  counterparts,  even  when   those  services  are  free   of  charge  and  widely  available.     The  Oportunidades  project  in   Mexico  is  redressing  the  balance.   Bulletin of the World Health Organization August 2006, 84 (8) TB:  impa)o  epidemiologico  sociale   20   3°convegno  nazionale  TB  –  Milano  09/12  
  • 21. The role of social protection in TB control 1.  TB care & control: •  Improve acceptability, relevance and attractiveness of services •  Enable access to improve early and free diagnosis •  Support patients, families and communities to improve outcomes 2.  Health systems and policies: •  Universal health coverage, including social & financial protection •  Integrated approach to address patients' health and social needs 3.  Sustainable development: •  Contribute to poverty reduction for TB patients, families, communities, and vulnerable groups 4.  Research: •  Build evidence base through operational research on delivery models, feasibility, local adaptation, and cost-effectiveness TB:  impa)o  epidemiologico  sociale   21   3°convegno  nazionale  TB  –  Milano  09/12  
  • 22. Enabler  and  social  protec?on  package   1.  Free  clinical  package   –  TB  diagnosis  and  treatment   –  Co-­‐morbidi?es  (HIV,  substance  abuse,   undernutri?on,  diabetes,  etc)   2.  Support  package   –  Health  informa?on  and  psychosocial  support   –  Cash  transfer   –  Travel  vouchers   –  Food  assistance   –  Housing  assistance   –  Voca?onal  training,  income  genera?on,   microcredit   3.  Regulaon  and  structural  intervenons   –  Workers'  protec?on     –  Sickness  insurance  &  welfare  benefits   TB:  impa)o  epidemiologico  sociale   22   3°convegno  nazionale  TB  –  Milano  09/12  
  • 23. Acknowledgements:    Mario  Raviglione    Knut  Lönnroth    Ernesto  Jaramillo        others  at  the  Stop  TB  Dept   TB:  impa)o  epidemiologico  sociale   23   3°convegno  nazionale  TB  –  Milano  09/12